Loading…
Phase I Study of Epigenetic Priming with Azacitidine Prior to Standard Neoadjuvant Chemotherapy for Patients with Resectable Gastric and Esophageal Adenocarcinoma: Evidence of Tumor Hypomethylation as an Indicator of Major Histopathologic Response
Schneider, Bryan J., Shah, Manish A., Klute, Kelsey, Ocean, Allyson, Popa, Elizabeta, Altorki, Nasser, Lieberman, Michael, Schreiner, Andrew, Yantiss, Rhonda, Christos, Paul J., Palmer, Romae, You, Daoqi, Viale, Agnes, Kermani, Pouneh, Scandura, Joseph M.
Published in Clinical cancer research (01.06.2017)
Published in Clinical cancer research (01.06.2017)
Get full text
Journal Article
Loading…
Evaluation of noncytotoxic DNMT1-depleting therapy in patients with myelodysplastic syndromes
Saunthararajah, Yogen, Sekeres, Mikkael, Advani, Anjali, Mahfouz, Reda, Durkin, Lisa, Radivoyevitch, Tomas, Englehaupt, Ricki, Juersivich, Joy, Cooper, Kathleen, Husseinzadeh, Holleh, Przychodzen, Bartlomiej, Rump, Matthew, Hobson, Sean, Earl, Marc, Sobecks, Ronald, Dean, Robert, Reu, Frederic, Tiu, Ramon, Hamilton, Betty, Copelan, Edward, Lichtin, Alan, Hsi, Eric, Kalaycio, Matt, Maciejewski, Jaroslaw
Published in The Journal of clinical investigation (01.03.2015)
Published in The Journal of clinical investigation (01.03.2015)
Get full text
Journal Article
Loading…
A phase II study of decitabine and gemtuzumab ozogamicin in newly diagnosed and relapsed acute myeloid leukemia and high-risk myelodysplastic syndrome
Daver, N, Kantarjian, H, Ravandi, F, Estey, E, Wang, X, Garcia-Manero, G, Jabbour, E, Konopleva, M, O'Brien, S, Verstovsek, S, Kadia, T, Dinardo, C, Pierce, S, Huang, X, Pemmaraju, N, Diaz-Pines-Mateo, M, Cortes, J, Borthakur, G
Published in Leukemia (01.02.2016)
Published in Leukemia (01.02.2016)
Get full text
Journal Article
Loading…
Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML
Scandura, Joseph M., Roboz, Gail J., Moh, Michelle, Morawa, Ewelina, Brenet, Fabienne, Bose, J. Robi, Villegas, Luis, Gergis, Usama S., Mayer, Sebastian A., Ippoliti, Cindy M., Curcio, Tania J., Ritchie, Ellen K., Feldman, Eric J.
Published in Blood (11.08.2011)
Published in Blood (11.08.2011)
Get full text
Journal Article
Loading…
Randomized study of continuous high-dose lenalidomide, sequential azacitidine and lenalidomide, or azacitidine in persons 65 years and over with newly-diagnosed acute myeloid leukemia
Medeiros, Bruno C., McCaul, Kelly, Kambhampati, Suman, Pollyea, Daniel A., Kumar, Rajat, Silverman, Lewis R., Kew, Andrea, Saini, Lalit, Beach, CL, Vij, Ravi, Wang, Xiwei, Zhong, Jim, Gale, Robert Peter
Published in Haematologica (Roma) (01.01.2018)
Published in Haematologica (Roma) (01.01.2018)
Get full text
Journal Article
Loading…
Approval Summary: Azacitidine for Treatment of Myelodysplastic Syndrome Subtypes
Kaminskas, Edvardas, Farrell, Ann, Abraham, Sophia, Baird, Amy, Hsieh, Li-Shan, Lee, Shwu-Luan, Leighton, John K., Patel, Hasmukh, Rahman, Atiqur, Sridhara, Rajeshwara, Wang, Yong-Cheng, Pazdur, Richard
Published in Clinical cancer research (15.05.2005)
Published in Clinical cancer research (15.05.2005)
Get full text
Journal Article
Loading…
Delivery of 5-Aza-2′-Deoxycytidine to Cells Using Oligodeoxynucleotides
Yoo, Christine B., Jeong, Shinwu, Egger, Gerda, Liang, Gangning, Phiasivongsa, Pasit, Tang, Chunlin, Redkar, Sanjeev, Jones, Peter A.
Published in Cancer research (Chicago, Ill.) (01.07.2007)
Published in Cancer research (Chicago, Ill.) (01.07.2007)
Get full text
Journal Article
Loading…
Pharmacokinetics of different formulations of oral azacitidine (CC-486) and the effect of food and modified gastric pH on pharmacokinetics in subjects with hematologic malignancies
Laille, Eric, Savona, Michael R, Scott, Bart L, Boyd, Thomas E, Dong, Qian, Skikne, Barry
Published in Journal of clinical pharmacology (01.06.2014)
Published in Journal of clinical pharmacology (01.06.2014)
Get more information
Journal Article
Loading…
Impact of clinical features, cytogenetics, genetic mutations, and methylation dynamics of CDKN2B and DLC-1 promoters on treatment response to azacitidine
Martín, Iván, Navarro, Blanca, Serrano, Alicia, Villamón, Eva, Calabuig, Marisa, Solano, Carlos, Chaves, Felipe Javier, Yagüe, Nuria, Orts, Maribel, Amat, Paula, Fuentes, Azahara, Seda, Enrique, García, Francisca, Hernández-Boluda, Juan Carlos, Tormo, Mar
Published in Annals of hematology (01.03.2020)
Published in Annals of hematology (01.03.2020)
Get full text
Journal Article
Loading…
Combinatorial epigenetic therapy in diffuse large B cell lymphoma pre-clinical models and patients
Pera, Benet, Tang, Tiffany, Marullo, Rossella, Yang, Shao-Ning, Ahn, Haelee, Patel, Jayeshkumar, Elstrom, Rebecca, Ruan, Jia, Furman, Richard, Leonard, John, Cerchietti, Leandro, Martin, Peter
Published in Clinical epigenetics (22.07.2016)
Published in Clinical epigenetics (22.07.2016)
Get full text
Journal Article
Loading…
A pilot pharmacokinetic study of oral azacitidine
Garcia-Manero, G, Stoltz, M L, Ward, M R, Kantarjian, H, Sharma, S
Published in Leukemia (01.09.2008)
Published in Leukemia (01.09.2008)
Get full text
Journal Article
Loading…
Development of a Supercritical Fluid Chromatography-Tandem Mass Spectrometry Method for the Determination of Azacitidine in Rat Plasma and Its Application to a Bioavailability Study
Li, Dongpo, Zhang, Tianhong, Kou, Longfa, Zhang, Youxi, Sun, Jin, He, Zhonggui
Published in Molecules (Basel, Switzerland) (27.12.2013)
Published in Molecules (Basel, Switzerland) (27.12.2013)
Get full text
Journal Article
Loading…